These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 29750029)
1. Mortality in COPD patients according to clinical phenotypes. Golpe R; Suárez-Valor M; Martín-Robles I; Sanjuán-López P; Cano-Jiménez E; Castro-Añón O; Pérez de Llano LA Int J Chron Obstruct Pulmon Dis; 2018; 13():1433-1439. PubMed ID: 29750029 [TBL] [Abstract][Full Text] [Related]
2. Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study. Calle Rubio M; Casamor R; Miravitlles M Int J Chron Obstruct Pulmon Dis; 2017; 12():2373-2383. PubMed ID: 28848338 [TBL] [Abstract][Full Text] [Related]
3. Geographic variations of the prevalence and distribution of COPD phenotypes in Spain: "the ESPIRAL-ES study". Alcázar-Navarrete B; Trigueros JA; Riesco JA; Campuzano A; Pérez J Int J Chron Obstruct Pulmon Dis; 2018; 13():1115-1124. PubMed ID: 29692606 [TBL] [Abstract][Full Text] [Related]
4. Clinical phenotypes of COPD and health-related quality of life: a cross-sectional study. Chai CS; Liam CK; Pang YK; Ng DL; Tan SB; Wong TS; Sia JE Int J Chron Obstruct Pulmon Dis; 2019; 14():565-573. PubMed ID: 30880946 [TBL] [Abstract][Full Text] [Related]
5. Clinical phenotypes and heath-related quality of life of COPD patients in a rural setting in Malaysia - a cross-sectional study. Chai CS; Mos SB; Ng DL; Goh GM; Su AT; Ibrahim MAB; Musa ANB; Tan SB; Pang YK; Liam CK BMC Pulm Med; 2020 Sep; 20(1):254. PubMed ID: 32993591 [TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of chronic bronchitic, emphysematous and ACOS phenotypes in COPD patients with frequent exacerbations. Cheng Y; Tu X; Pan L; Lu S; Xing M; Li L; Chen X Int J Chron Obstruct Pulmon Dis; 2017; 12():2069-2074. PubMed ID: 28790809 [TBL] [Abstract][Full Text] [Related]
7. Smoking history and emphysema in asthma-COPD overlap. Kurashima K; Takaku Y; Ohta C; Takayanagi N; Yanagisawa T; Kanauchi T; Takahashi O Int J Chron Obstruct Pulmon Dis; 2017; 12():3523-3532. PubMed ID: 29263658 [TBL] [Abstract][Full Text] [Related]
8. Distribution and characteristics of COPD phenotypes - results from the Polish sub-cohort of the POPE study. Kania A; Krenke R; Kuziemski K; Czajkowska-Malinowska M; Celejewska-Wójcik N; Kuźnar-Kamińska B; Farnik M; Bokiej J; Miszczuk M; Damps-Konstańska I; Grabicki M; Trzaska-Sobczak M; Sładek K; Batura-Gabryel H; Barczyk A Int J Chron Obstruct Pulmon Dis; 2018; 13():1613-1621. PubMed ID: 29844667 [TBL] [Abstract][Full Text] [Related]
9. Active smoking and COPD phenotype: distribution and impact on prognostic factors. Riesco JA; Alcázar B; Trigueros JA; Campuzano A; Pérez J; Lorenzo JL Int J Chron Obstruct Pulmon Dis; 2017; 12():1989-1999. PubMed ID: 28740378 [TBL] [Abstract][Full Text] [Related]
10. Clinical Features Of Women With COPD: Sex Differences In A Cross-Sectional Study In Spain ("The ESPIRAL-ES Study"). Trigueros JA; Riesco JA; Alcázar-Navarrete B; Campuzano A; Pérez J Int J Chron Obstruct Pulmon Dis; 2019; 14():2469-2478. PubMed ID: 31806956 [TBL] [Abstract][Full Text] [Related]
11. The objective evaluation of obstructive pulmonary diseases with spirometry. Ozkaya S; Dirican A; Tuna T Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884 [TBL] [Abstract][Full Text] [Related]
12. Survival associated with chronic obstructive pulmonary disease among SEER-Medicare beneficiaries with non-small-cell lung cancer. Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R Int J Chron Obstruct Pulmon Dis; 2019; 14():893-903. PubMed ID: 31118599 [No Abstract] [Full Text] [Related]
13. COPD phenotypes: differences in survival. Hernández Vázquez J; Ali García I; Jiménez-García R; Álvaro Meca A; López de Andrés A; Matesanz Ruiz C; Buendía García MJ; de Miguel Díez J Int J Chron Obstruct Pulmon Dis; 2018; 13():2245-2251. PubMed ID: 30050297 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary disease. Camiciottoli G; Bigazzi F; Magni C; Bonti V; Diciotti S; Bartolucci M; Mascalchi M; Pistolesi M Int J Chron Obstruct Pulmon Dis; 2016; 11():2229-2236. PubMed ID: 27695310 [TBL] [Abstract][Full Text] [Related]
15. Mortality in Asthma-Chronic Obstructive Pulmonary Disease Overlap in the United States. Kumbhare S; Strange C South Med J; 2018 May; 111(5):293-298. PubMed ID: 29767222 [TBL] [Abstract][Full Text] [Related]
16. Lung and kidney: a dangerous liaison? A population-based cohort study in COPD patients in Italy. Fedeli U; De Giorgi A; Gennaro N; Ferroni E; Gallerani M; Mikhailidis DP; Manfredini R; Fabbian F Int J Chron Obstruct Pulmon Dis; 2017; 12():443-450. PubMed ID: 28184156 [TBL] [Abstract][Full Text] [Related]
17. Determining prognosis in acute exacerbation of COPD. Flattet Y; Garin N; Serratrice J; Perrier A; Stirnemann J; Carballo S Int J Chron Obstruct Pulmon Dis; 2017; 12():467-475. PubMed ID: 28203070 [TBL] [Abstract][Full Text] [Related]
18. Impact of COPD on prognosis of lung cancer: from a perspective on disease heterogeneity. Wang W; Dou S; Dong W; Xie M; Cui L; Zheng C; Xiao W Int J Chron Obstruct Pulmon Dis; 2018; 13():3767-3776. PubMed ID: 30538439 [TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of chronic obstructive pulmonary disease phenotypes. One center prospective study. Said A; Esmail M; Abdel Naiem E; Zaki Z; Raouf R Adv Respir Med; 2021; 89(4):369-377. PubMed ID: 34494240 [TBL] [Abstract][Full Text] [Related]
20. Comparison of in-hospital mortality in patients with COPD, asthma and asthma-COPD overlap exacerbations. Yamauchi Y; Yasunaga H; Matsui H; Hasegawa W; Jo T; Takami K; Fushimi K; Nagase T Respirology; 2015 Aug; 20(6):940-6. PubMed ID: 25998444 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]